What is the IVA Market Size?
According to 6Wresearch internal database and industry insights, the IVA (Intravenous Anaesthesia) market was valued at USD 2.8 billion in 2025 and is projected to exceed USD 4.9 billion by 2032, growing at a CAGR of 7.3% during the forecast period.
The market growth is attributed to the increasing adoption of intravenous anaesthesia agents in outpatient surgeries, advancements in drug delivery systems, and growing awareness about faster recovery and reduced postoperative side effects. The market is also driven by the rising geriatric population undergoing surgeries and the expansion of ambulatory surgical centres globally.
Major Growth Factors of the IVA Market
- Rising number of outpatient and ambulatory surgeries
- Increasing adoption of IV sedatives due to rapid onset and recovery
- Advancements in intravenous drug delivery technologies
- Growing elderly population and chronic disease prevalence
- Surge in minimally invasive surgical procedures
- Preference for personalized and target-specific aesthetic agents
- Cost-efficiency of intravenous anaesthesia in short-duration surgeries
- Expansion of healthcare infrastructure in emerging markets
IVA Market Trends
The IVA market is estimated to experience an increased demand for short-acting agents and patient-specific anaesthesia protocols. There is a move towards drugs with reduced side effects and faster recovery times. Technological incorporation for precise dosing and monitoring is becoming central to clinical practices. Clean-label and preservative-free formulations are also gaining traction among healthcare providers.
Emerging Developments in the IVA Market
The IVA market is experiencing notable emergence such as the launch of new propofol-based formulations and combination therapies. Pharmaceutical companies are investing in biosimilar IV anaesthetics and nanotechnology-enhanced drug carriers. Moreover, associations between pharma and healthcare tech firms are introducing smart infusion systems that support IV anaesthesia delivery.
Major Companies in the IVA Market
- Pfizer Inc.
- Fresenius Kabi AG
- Baxter International Inc.
- B. Braun Melsungen AG
- Hikma Pharmaceuticals PLC
- AbbVie Inc.
- Mylan N.V.
- Dr. Reddy’s Laboratories Ltd.
How big is the IVA market : FAQs
The IVA market was projected to be valued at USD 2.8 billion in 2025 and expected to surpass USD 4.9 billion by 2031.
The IVA market is forecast to grow at a CAGR of 7.3% during the period from 2025 to 2031.
Key trends include increasing demand for rapid-onset anaesthetics, clean-label IV formulations, and integration of smart infusion technologies.
The IVA market is driven by rising surgical volumes, demand for cost-effective anaesthesia in day-care procedures, and innovations in IV drug delivery systems.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com